Montair Chewable Tablet 5mg
Last Updated: December 30, 2025
| Product Name | Montair Chewable Tablet |
| Active Ingredient | Montelukast |
| Effect |
Improvement of symptoms of allergic rhinitis and bronchial asthma
|
| Strength | 5mg |
| Delivery Time | 7~14 days |
| Target Gender | Unisex |
| Manufacturer | Cipla Ltd |
Dr. David Harrilla
Drug Safety Expert & Specialist in Generic Medicine
View more »
Niamh Stovall
Senior Medical Content Writer
10+ Years Health Journalism
Product Details of Montair Chewable 5mg
Montair Chewable Tablet is a product that is favored by those who want to prevent bronchial asthma attacks.
Montair Chewable Tablet is a drug with a relatively new mechanism of action and is classified as a leukotriene receptor antagonist.
It blocks the substances that cause itching and inflammation from acting, so it is also recommended for those who cannot control their symptoms with antihistamines.
Another advantage is that you can chew and take without water.
Effect of Montair Chewable
Montair 5mg interferes with the action of leukotriene, an pro-inflammatory substance, and is effective in preventing bronchial asthma attacks and treating allergic rhinitis.
Please note that asthma does not directly stop seizures. In the event of a seizure, use an inhaler that widens the bronchi.
Duration of action of Montair Chewable
It is not a type that has an immediate effect, and the effect begins to appear in about 2 to 4 weeks after continuing to take it.
To prevent asthma attacks, continue as directed by your doctor even if you do not have an asthma attack.
Indications for Montair Chewable
Montair Chewable Tablet improves the following symptoms:
- Those who want to prevent bronchial asthma attacks
- Those who are suspected of having bronchial asthma
- Those who continue to have asthma-like symptoms
- Those who are suffering from allergic rhinitis
Active ingredient of Montair Chewable
Contains montelukast sodium as an active ingredient.
This ingredient binds to leukotriene receptors and prevents bronchial contraction so that an inflammation-inducing substance called leukotriene does not work.
Pharmaceutical company
Cipla is a pharmaceutical company based in India with a history of more than 80 years.
We manufacture cheap AIDS medicines for HIV patients in emerging countries.
How to take Montair Chewable 5mg
Usually, take 5 mg (1 tablet) of Montair Chewable Tablet once a day before going to bed.
Please chew it in your mouth, dissolve it in saliva and drink.
It is important to continue taking it for as long as your doctor tells you.
Recommended dose of Montair Chewable
Asthma attacks can be painful from night to morning and are recommended to be taken before bedtime.
Do not take with alcohol, caffeine drinks, sugary juices, etc. In general, the absorption of medicines may be poor.
Even if your asthma attack disappears, do not stop taking it at your own discretion. If you are taking other medicines, please consult your doctor or pharmacist. There may be cases where you have a bad drink.
Precautions when taking Montair Chewable
- Pregnant women, lactating women, newborn babies, etc. may not be able to take this medicine. Be sure to follow your doctor’s instructions.
- If you take this medicine for a long period of time, please take regular inspections.
- If you are on long-term steroid therapy or want to reduce or stop steroids by taking this drug, consult your doctor and take it carefully.
Side effects of Montair Chewable 5mg
Gastrointestinal symptoms such as rash, pruritus, somnolence, headache, and diarrhea, abnormal liver function test values, dry mouth, and urinary occult blood have been reported.
If you feel any discomfort after taking this medicine, stop taking it and consult your doctor or pharmacist.
Precautions for use Montair Chewable 5mg
The following people should be careful in using it.
- Do not use it for sudden asthma attacks — it does not work fast enough.
- Tell your doctor if you have liver problems or are taking other medicines.
- Use it regularly as prescribed, even if you feel well — don’t stop suddenly.
- Watch for mood or behavior changes (irritability, agitation, depression, suicidal thoughts) and report them.
- Pregnant or breastfeeding women should consult a doctor before use.
- Avoid alcohol and inform your doctor about allergies or aspirin sensitivity.
How to store Montair Chewable 5mg
- Store at room temperature (1–30 °C)
- Keep out of reach of children and pet.
- Keep away from direct sunlight, moisture.
- Do not refrigerate
- Do not use after the expiry date
- For half-tablets, wrap in foil or store in a sealed pill box to prevent moisture damage
Frequently Asked Questions
What is Montair Chewable 5mg used for?
Montair Chewable 5mg is used to treat asthma, allergic rhinitis (sneezing, runny nose), and breathing problems. It helps relax the airways so you can breathe better.
How should I take Montair Chewable 5mg?
Usually, it is taken once daily in the evening, with or without food. Always follow your doctor’s instructions.
Can I use Montair Chewable 5mg during an asthma attack?
No, Montair Chewable 5mg does not work fast enough for sudden attacks. Use your rescue inhaler instead.
Is Montair Chewable 5mg safe for long-term use?
Yes, Doctors often prescribe it for long-term control of asthma and allergies — but only under medical supervision.
Can Montair Chewable 5mg affect mood?
Rarely, some people may feel irritability, anxiety, sleep problems, or mood changes. Tell your doctor if this happens.
| Pack Size | 150 Tablets, 300 Tablets |
|---|
Brand
Cipla
About Cipla (Pharmaceutical company)
Cipla Limited is an Indian multinational pharmaceutical company, headquartered in Mumbai, India. Cipla primarily develops medicines to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression and many other medical conditions. Cipla, as an organisation has been built brick-by-brick on the foundation of care. Caring For Life has always been and continues to remain, our guiding purpose. Driven by the same purpose, we have extended our presence to 80+ countries providing over 1,500 products across various therapeutic categories in 50+ dosage forms. To make healthcare more affordable globally, we are deepening our presence in the key markets of India, South Africa, the U.S. among other economies of the emerging world. For over eight decades, making a difference to patients has inspired every aspect of Cipla’s work. Our paradigm-changing offer of a triple anti-retroviral therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 is widely acknowledged as having contributed to bringing inclusiveness, accessibility and affordability to the centre of the HIV movement. A responsible corporate citizen, Cipla’s humanitarian approach to healthcare in pursuit of its purpose of Caring for Life and deep-rooted community links wherever it is present, make it a partner of choice for global health bodies and stakeholders.
| Company Name | Cipla |
| location | Mumbai, India |
| Year of establishment | 1935 |
| Representative | Umang Vohra (CEO) |
| Official Website | https://www.cipla.com/ |
Only logged in customers who have purchased this product may leave a review.






Reviews
There are no reviews yet.